Location History:
- Sichuan, CN (2020)
- Chengdu, CN (2021)
Company Filing History:
Years Active: 2020-2021
Title: The Innovative Contributions of Yufeng Liang in Biopharmaceuticals
Introduction
Yufeng Liang is a prominent inventor based in Chengdu, China, recognized for his significant contributions to the field of biopharmaceuticals. With a total of two patents to his name, Liang's work primarily focuses on the development of innovative compounds that can aid in the treatment of various viral infectious diseases.
Latest Patents
Liang's most recent inventions include two groundbreaking patents. The first patent details a phosphonamide ester compound, along with its salts and related crystal forms. This invention introduces a chiral synthesis and chiral isolation method, providing a pharmaceutical composition that can be utilized in the treatment of viral infectious diseases, notably hepatitis B. The second patent pertains to a solid form of a 4'-thio-2′-fluoronucleoside phosphamide compound, which includes the preparation method for the solid form and its applications in treating diseases involved with abnormal cell proliferation or viral infectious diseases.
Career Highlights
Yufeng Liang is affiliated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His research and inventions reflect a deep commitment to advancing medical science and improving treatment options for patients suffering from infectious diseases.
Collaborations
Throughout his career, Liang has collaborated with esteemed colleagues, including Qiang Tian and Mingliang Zhao. These partnerships foster a collaborative atmosphere that contributes to the innovation and refinement of their scientific research.
Conclusion
In conclusion, Yufeng Liang's inventive contributions stand out in the biopharmaceutical sector. His patents not only demonstrate his ingenuity but also his dedication to addressing significant health challenges. As he continues his research at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., the medical community eagerly anticipates further advancements from this talented inventor.